Hi All. new to the message boards. What do you consider a major shareholder in this company?
Would love to toot their horn.
As stock goes up, acquisition tag gets much steeper. Is 3 billion now too cheap?
1. Most effective in class by wide margin. 2. most cost effective by wide margin.
3. MDT doesn't play along with a product for nickels - they are in it for dollars
4. Future potential revenue for the miracle placenta potion ~ $14 billion.
Tell me: is $50/share out of the question in 2 years?
And don't gauge it from a bricks and mortar but as a biotech on steroids.
Company will be worth 2 billion+ within 2 years (buy out or not). Regarding the injectable, lets keep some things in mind: 1) Steroids injections are dirt cheap, 2) Most Payers will not reimburse without indications. PRP has been around much longer and lacks wise reimbursement. This landscape is not chaining anytime soon. 3) Orthopedic Guidelines. Steroids, while palliative, is a part of the literature.
Many years from now, Amniofix should be huge and used widely for many sport med type applications. What's it's worth is really up to what managed care will pay for at that time.
Yes steroids are cheap but take a look at the explosion in ophthalmology in just 1-2 years in antibody fragment injections (ie, Lucentis, Avastin) for macular degeneration. Efficacy trumps cost even in the insurance world. Once indicated thru literature, and covered by CMS, insurers generally jump on the bandwagon.
Classic steady rise to close out shorts at year end. I expect us to challenge $9 today!
If we have a new investor who is exuberant, irrational or otherwise, best to stay out of their way. I'm not sure how we get a $4+ billion company out of MDXG but much sillier valuations have occured and will occur.
Personally, when Pete advertises in the Super Bowl, I'm out of here!
And Apple will never see $700 and Amgen will never see $100 and Netflix will never see $300.
Remember we are talking about a miracle maker here - and someone (MDXG) has cornered the market. Most people have 2 knees, 2 hips, 2 feet, 2 shoulders, and 1 long spine. If you replace cortisone injections and don't get acquired, stock will easily be $100/share in 5 years.
So explain why it will never see $50/share?